Does RIFAXIMIN Cause Hepatocellular carcinoma? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Hepatocellular carcinoma have been filed in association with RIFAXIMIN (XIFAXAN). This represents 0.1% of all adverse event reports for RIFAXIMIN.
20
Reports of Hepatocellular carcinoma with RIFAXIMIN
0.1%
of all RIFAXIMIN reports
7
Deaths
12
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From RIFAXIMIN?
Of the 20 reports, 7 (35.0%) resulted in death, 12 (60.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAXIMIN. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAXIMIN Cause?
Death (3,687)
Hospitalisation (1,605)
Therapy interrupted (875)
Off label use (802)
Diarrhoea (709)
Ammonia increased (676)
Inability to afford medication (672)
Insurance issue (577)
Confusional state (530)
Hepatic cirrhosis (480)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which RIFAXIMIN Alternatives Have Lower Hepatocellular carcinoma Risk?
RIFAXIMIN vs RILMENIDINE
RIFAXIMIN vs RILONACEPT
RIFAXIMIN vs RILPIVIRINE
RIFAXIMIN vs RILUZOLE
RIFAXIMIN vs RIMABOTULINUMTOXINB